Stay updated on Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Sign up to get notified when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page shows an update to the revision metadata with an addition of 'Revision: v3.3.4' and a deletion of 'Revision: v3.3.3'. This appears to be a metadata/versioning update and does not modify study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:46:05.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new 'Locations' section has been added, including New Jersey and New York. The previous 'New Jersey Locations' and 'New York Locations' sections have been removed.
    Difference
    0.3%
    Check dated 2025-12-23T17:16:40.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added note that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed publication description and the old revision text were removed (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T21:33:01.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page no longer displays the government funding and operating-status notice that advised users about potential delays and directed them to cc.nih.gov and opm.gov for updates.
    Difference
    0.4%
    Check dated 2025-11-17T19:52:09.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The study details, eligibility criteria, and interventions appear unchanged; only formatting and layout updates are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:46:57.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T04:23:08.000Z thumbnail image

Stay in the know with updates to Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.